DCAF7 was overexpressed in most cancers, consistent with copy‐number gain, focal promoter hypomethylation and putative m6A‐linked post‐transcriptional regulation, whereas hypermethylation at two CpG loci predicted poor prognosis in LIHC. The gene discussed is DCAF7; the disease is cancer.